Dr. Reddy's Lab - AI-Powered Stock Analysis & Investment Research | EQHQ

Share

Search your stocks

Ctrl+K

DRREDDYDr. Reddy's Lab

₹1200+0.33%

Market Cap

₹99,965.86 Cr

Stock P/E

17.32

ROCE

23.25%

ROE

18.61%

Book Value

₹431.50

Financials

YoY Net Sales

EPS Growth

Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Foreign Investors

Domestic Investors

Public

From Last Concall

POSITIVES

•
Revenue momentum: double-digit growth with 11% YoY topline expansion.
•
Healthy profitability: EBITDA margin at 27% versus target of 25%.

NEGATIVES

•
US base business weakness driven by timing and Lenalidomide impact.
•
Lenalidomide pricing pressure contributing to margin erosion.

Peers Summary

No Peers Data

Peer comparison data is not available for this stock.